-
1
-
-
0013881809
-
La tachycardie ventriculaire a deux foyers opposes variables
-
Feb
-
Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur Vaiss 1966 Feb; 59 (2): 263-72.
-
(1966)
Arch Mal Coeur Vaiss
, vol.59
, Issue.2
, pp. 263-72
-
-
Dessertenne, F.1
-
2
-
-
67349175359
-
Drug-induced arrhythmias and sudden cardiac death: Implications for the pharmaceutical industry
-
Jun
-
Killeen MJ. Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry. Drug Discov Today 2009 Jun; 14 (11-12): 589-97.
-
(2009)
Drug Discov Today
, vol.14
, Issue.11-12
, pp. 589-97
-
-
Killeen, M.J.1
-
3
-
-
0034780262
-
The negative autopsy: Sudden cardiac death or other?
-
DOI 10.1016/S1054-8807(01)00093-X, PII S105488070100093X
-
Cohle SD, Sampson BA. The negative autopsy: sudden cardiac death or other? Cardiovasc Pathol 2001 Sep-Oct; 10 (5): 219-22. (Pubitemid 32982882)
-
(2001)
Cardiovascular Pathology
, vol.10
, Issue.5
, pp. 219-222
-
-
Cohle, S.D.1
Sampson, B.A.2
-
4
-
-
67649268399
-
Drug-induced changes in the T-wave morphology
-
Malik M. Drug-induced changes in the T-wave morphology. Drug Saf 2009; 32 (7): 613-7.
-
(2009)
Drug Saf
, vol.32
, Issue.7
, pp. 613-7
-
-
Malik, M.1
-
6
-
-
18444386801
-
Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men
-
DOI 10.1111/j.1542-474X.2005.05604.x
-
Dogan A, Tunc E, Varol E, et al. Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men. Ann Noninvasive Electrocardiol 2005 Apr; 10 (2): 134-41. (Pubitemid 40646653)
-
(2005)
Annals of Noninvasive Electrocardiology
, vol.10
, Issue.2
, pp. 134-141
-
-
Dogan, A.1
Tunc, E.2
Varol, E.3
Ozaydin, M.4
Ozturk, M.5
-
7
-
-
0030058329
-
Diurnal pattern of QTc interval: How long is prolonged? Possible relation to cir-cadian triggers of cardiovascular events
-
Jan
-
Molnar J, Zhang F, Weiss J, et al. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to cir-cadian triggers of cardiovascular events. J Am Coll Car-diol 1996 Jan; 27 (1): 76-83.
-
(1996)
J Am Coll Car-diol
, vol.27
, Issue.1
, pp. 76-83
-
-
Molnar, J.1
Zhang, F.2
Weiss, J.3
-
8
-
-
30744470720
-
Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention
-
DOI 10.1192/apt.12.2.100
-
Abdelmawla N, Mitchell A. Sudden cardiac death and antipsychotics, part 2: monitoring and prevention. Adv Psychiatr Treat 2006; 12: 100-9. (Pubitemid 43338103)
-
(2006)
Advances in Psychiatric Treatment
, vol.12
, Issue.2
, pp. 100-109
-
-
Abdelmawla, N.1
Mitchell, A.J.2
-
9
-
-
79955413065
-
The safety of atypical antipsychotics: Does QTc provide all the answers?
-
May
-
Nielsen J. The safety of atypical antipsychotics: does QTc provide all the answers? Expert Opin Drug Saf 2011 May; 10 (3): 341-4.
-
(2011)
Expert Opin Drug Saf
, vol.10
, Issue.3
, pp. 341-4
-
-
Nielsen, J.1
-
10
-
-
34548224606
-
Cardiovascular risks of atypical antipsychotic drug treatment
-
DOI 10.1002/pds.1424
-
Drici MD, Priori S. Cardiovascular risks of atypical anti- psychotic drug treatment. Pharmacoepidemiol Drug Saf 2007 Aug; 16 (8): 882-90. (Pubitemid 47322588)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.8
, pp. 882-890
-
-
Drici, M.-D.1
Priori, S.2
-
11
-
-
70449435450
-
The genetic basis of long QT and short QT syndromes: A mutation update
-
Nov
-
Hedley PL, Jorgensen P, Schlamowitz S, et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009 Nov; 30 (11): 1486-511.
-
(2009)
Hum Mutat
, vol.30
, Issue.11
, pp. 1486-511
-
-
Hedley, P.L.1
Jorgensen, P.2
Schlamowitz, S.3
-
12
-
-
33748058449
-
Cost-effectiveness of neonatal ECG screening for the long QT syndrome
-
DOI 10.1093/eurheartj/ehl115
-
Quaglini S, Rognoni C, Spazzolini C, et al. Cost-effective- ness of neonatal ECG screening for the long QT syndrome. Eur Heart J 2006 Aug; 27 (15): 1824-32. (Pubitemid 44297389)
-
(2006)
European Heart Journal
, vol.27
, Issue.15
, pp. 1824-1832
-
-
Quaglini, S.1
Rognoni, C.2
Spazzolini, C.3
Priori, S.G.4
Mannarino, S.5
Schwartz, P.J.6
-
13
-
-
77953483936
-
Drug- and non- drug-associated QT interval prolongation
-
Jul
-
van Noord C, Eijgelsheim M, Stricker BH. Drug- and non- drug-associated QT interval prolongation. Br J Clin Pharmacol 2010 Jul; 70 (1): 16-23.
-
(2010)
Br J Clin Pharmacol
, vol.70
, Issue.1
, pp. 16-23
-
-
Van Noord, C.1
Eijgelsheim, M.2
Stricker, B.H.3
-
14
-
-
0037161355
-
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
-
DOI 10.1161/01.CIR.0000014448.19052.4C
-
Yang P, Kanki H, Drolet B, et al. Allelic variants in long- QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002 Apr 23; 105 (16): 1943-8. (Pubitemid 34437622)
-
(2002)
Circulation
, vol.105
, Issue.16
, pp. 1943-1948
-
-
Yang, P.1
Kanki, H.2
Drolet, B.3
Yang, T.4
Wei, J.5
Viswanathan, P.C.6
Hohnloser, S.H.7
Shimizu, W.8
Schwartz, P.J.9
Stanton, M.10
Murray, K.T.11
Norris, K.12
George Jr., A.L.13
Roden, D.M.14
-
15
-
-
5444264579
-
Genetic variations of HCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients
-
DOI 10.1007/s00109-003-0522-z
-
Paulussen AD, Gilissen RA, Armstrong M, et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 2004 Mar; 82 (3): 182-8. (Pubitemid 38392168)
-
(2004)
Journal of Molecular Medicine
, vol.82
, Issue.3
, pp. 182-188
-
-
Paulussen, A.D.C.1
Gilissen, R.A.H.J.2
Armstrong, M.3
Doevendans, P.A.4
Verhasselt, P.5
Smeets, H.J.M.6
Schulze-Bahr, E.7
Haverkamp, W.8
Breithardt, G.9
Cohen, N.10
Aerssens, J.11
-
16
-
-
34247397075
-
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes
-
DOI 10.1016/j.hrthm.2007.01.019, PII S1547527107000501
-
Lehtonen A, Fodstad H, Laitinen-Forsblom P, et al. Fur- ther evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm 2007 May; 4 (5): 603-7. (Pubitemid 46655584)
-
(2007)
Heart Rhythm
, vol.4
, Issue.5
, pp. 603-607
-
-
Lehtonen, A.1
Fodstad, H.2
Laitinen-Forsblom, P.3
Toivonen, L.4
Kontula, K.5
Swan, H.6
-
17
-
-
63849311301
-
Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation
-
Apr
-
van Noord C, Aarnoudse AJ, Eijgelsheim M, et al. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation. Pharmacogenet Genomics 2009 Apr; 19 (4): 260-6.
-
(2009)
Pharmacogenet Genomics
, vol.19
, Issue.4
, pp. 260-6
-
-
Van Noord, C.1
Aarnoudse, A.J.2
Eijgelsheim, M.3
-
18
-
-
0035150202
-
Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death
-
DOI 10.1176/appi.ajp.158.11.1774
-
Glassman AH, Bigger Jr JT. Antipsychotic drugs: pro- longed QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001 Nov; 158 (11): 1774-82. (Pubitemid 33054769)
-
(2001)
American Journal of Psychiatry
, vol.158
, Issue.11
, pp. 1774-1782
-
-
Glassman, A.H.1
Bigger Jr., J.T.2
-
19
-
-
61849129618
-
Dispersions of re- polarization and ventricular arrhythmogenesis: Lessons from animal models
-
Oct-Nov
-
Killeen MJ, Sabir IN, Grace AA, et al. Dispersions of re- polarization and ventricular arrhythmogenesis: lessons from animal models. Prog Biophys Mol Biol 2008 Oct-Nov; 98 (2-3): 219-29.
-
(2008)
Prog Biophys Mol Biol
, vol.98
, Issue.2-3
, pp. 219-29
-
-
Killeen, M.J.1
Sabir, I.N.2
Grace, A.A.3
-
22
-
-
2342484491
-
Prolonged QTc Interval and Risks of Total and Cardiovascular Mortality and Sudden Death in the General Population: A Review and Qualitative Overview of the Prospective Cohort Studies
-
DOI 10.1001/archinte.164.9.943
-
Montanez A, Ruskin JN, Hebert PR, et al. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med 2004 May 10; 164 (9): 943-8. (Pubitemid 38581512)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.9
, pp. 943-948
-
-
Montanez, A.1
Ruskin, J.N.2
Hebert, P.R.3
Lamas, G.A.4
Hennekens, C.H.5
-
23
-
-
15844417196
-
Torsade de pointes in patients on chronic amiodarone treatment: Contributing factors and drug interactions
-
Antonelli D, Atar S, Freedberg NA, et al. Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions. Isr Med Assoc J 2005 Mar; 7 (3): 163-5. (Pubitemid 40424960)
-
(2005)
Israel Medical Association Journal
, vol.7
, Issue.3
, pp. 163-165
-
-
Antonelli, D.1
Atar, S.2
Freedberg, N.A.3
Rosenfeld, T.4
-
24
-
-
39349107214
-
QT and TdP. QT an unreliable predictor of proarrhythmia
-
Feb
-
Hondeghem LM. QT and TdP. QT: an unreliable predictor of proarrhythmia. Acta Cardiol 2008 Feb; 63 (1): 1-7.
-
(2008)
Acta Cardiol
, vol.63
, Issue.1
, pp. 1-7
-
-
Hondeghem, L.M.1
-
25
-
-
68949172254
-
11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study)
-
Aug 22
-
Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009 Aug 22; 374 (9690): 620-7.
-
(2009)
Lancet
, vol.374
, Issue.9690
, pp. 620-7
-
-
Tiihonen, J.1
Lonnqvist, J.2
Wahlbeck, K.3
-
26
-
-
0035021986
-
Evaluation of drug-induced QT interval prolongation: Implications for drug approval and labelling
-
Malik M, Camm AJ. Evaluation of drug-induced QT in- terval prolongation: implications for drug approval and labelling. Drug Saf 2001; 24 (5): 323-51. (Pubitemid 32417533)
-
(2001)
Drug Safety
, vol.24
, Issue.5
, pp. 323-351
-
-
Malik, M.1
Camm, A.J.2
-
27
-
-
34548165798
-
Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy
-
DOI 10.1016/j.cpcardiol.2007.05.002, PII S0146280607000680
-
Turakhia M, Tseng ZH. Sudden cardiac death: epidemiol- ogy, mechanisms, and therapy. Curr Probl Cardiol 2007 Sep; 32 (9): 501-46. (Pubitemid 47304457)
-
(2007)
Current Problems in Cardiology
, vol.32
, Issue.9
, pp. 501-546
-
-
Turakhia, M.1
Tseng, Z.H.2
-
29
-
-
0034945769
-
Is gender a risk factor for adverse drug reactions? The example of drug-induced long qt syndrome
-
Drici MD, Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 2001; 24 (8): 575-85. (Pubitemid 32656071)
-
(2001)
Drug Safety
, vol.24
, Issue.8
, pp. 575-585
-
-
Drici, M.-D.1
Clement, N.2
-
30
-
-
77957350060
-
Safety of sertindole versus risperidone in schizophrenia: Principal results of the sertindole cohort prospective study (SCoP)
-
Thomas SH, Drici MD, Hall GC, et al. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatr Scand 2010; 122 (5): 345-55.
-
(2010)
Acta Psychiatr Scand
, vol.122
, Issue.5
, pp. 345-55
-
-
Thomas, S.H.1
Drici, M.D.2
Hall, G.C.3
-
31
-
-
0025759005
-
Mortality in a cohort of patients with schizophrenia: A record linkage study
-
May
-
Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991 May; 36 (4): 239-45.
-
(1991)
Can J Psychiatry
, vol.36
, Issue.4
, pp. 239-45
-
-
Newman, S.C.1
Bland, R.C.2
-
32
-
-
58349114259
-
Atypical antipsychotic drugs and the risk of sudden cardiac death
-
Jan
-
Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009 Jan 15; 360 (3): 225-35.
-
(2009)
N Engl J Med
, vol.15-360
, Issue.3
, pp. 225-35
-
-
Ray, W.A.1
Chung, C.P.2
Murray, K.T.3
-
33
-
-
35148893170
-
Physical illness and schizophrenia: A review of the literature
-
DOI 10.1111/j.1600-0447.2007.01095.x
-
Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007 Nov; 116 (5): 317-33. (Pubitemid 47537428)
-
(2007)
Acta Psychiatrica Scandinavica
, vol.116
, Issue.5
, pp. 317-333
-
-
Leucht, S.1
Burkard, T.2
Henderson, J.3
Maj, M.4
Sartorius, N.5
-
34
-
-
49549091129
-
Drug-induced long QT syndrome and drug de- velopment
-
Sep
-
Ritter JM. Drug-induced long QT syndrome and drug de- velopment. Br J Clin Pharmacol 2008 Sep; 66 (3): 341-4.
-
(2008)
Br J Clin Pharmacol
, vol.66
, Issue.3
, pp. 341-4
-
-
Ritter, J.M.1
-
35
-
-
0030694189
-
Excess mortality of schizophrenia: A meta-analysis
-
Dec
-
Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry 1997 Dec; 171: 502-8.
-
(1997)
Br J Psychiatry
, vol.171
, pp. 502-8
-
-
Brown, S.1
-
36
-
-
0035739287
-
A case series of drug-induced long QT syndrome and Torsade de Pointes
-
Tong KL, Lau YS, Teo WS. A case series of drug-induced long QT syndrome and torsade de pointes. Singapore Med J 2001 Dec; 42 (12): 566-70. (Pubitemid 34594612)
-
(2001)
Singapore Medical Journal
, vol.42
, Issue.12
, pp. 566-570
-
-
Tong, K.L.1
Lau, Y.S.2
Teo, W.S.3
-
37
-
-
25844479293
-
QTc interval prolongation and antipsychotic drug treatments: Focus on sertindole
-
DOI 10.1017/S1461145705005250, PII S1461145705005250
-
Lindstrom E, Farde L, Eberhard J, et al. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole. Int J Neuropsychopharmacol 2005 Dec; 8 (4): 615-29. (Pubitemid 41400893)
-
(2005)
International Journal of Neuropsychopharmacology
, vol.8
, Issue.4
, pp. 615-629
-
-
Lindstrom, E.1
Farde, L.2
Eberhard, J.3
Haverkamp, W.4
-
38
-
-
0037309793
-
Antipsychotics and QT prolongation
-
DOI 10.1034/j.1600-0447.2003.02078.x
-
Taylor DM. Antipsychotics and QT prolongation. Acta Psychiatr Scand 2003 Feb; 107 (2): 85-95. (Pubitemid 36164475)
-
(2003)
Acta Psychiatrica Scandinavica
, vol.107
, Issue.2
, pp. 85-95
-
-
Taylor, D.M.1
-
39
-
-
0037823364
-
Torsade de pointes due to noncardiac drugs: Most patients have easily identifiable risk factors
-
DOI 10.1097/00005792-200307000-00007
-
Zeltser D, Justo D, Halkin A, et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 2003 Jul; 82 (4): 282-90. (Pubitemid 36859224)
-
(2003)
Medicine
, vol.82
, Issue.4
, pp. 282-290
-
-
Zeltser, D.1
Justo, D.2
Halkin, A.3
Prokhorov, V.4
Heller, K.5
Viskin, S.6
-
40
-
-
0027474601
-
Mechanism of the cardiotoxic actions of terfenadine
-
DOI 10.1001/jama.269.12.1532
-
Woosley RL, Chen Y, Freiman JP, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993 Mar 24-31; 269 (12): 1532-6. (Pubitemid 23086414)
-
(1993)
Journal of the American Medical Association
, vol.269
, Issue.12
, pp. 1532-1536
-
-
Woosley, R.L.1
Chen, Y.2
Freiman, J.P.3
Gillis, R.A.4
-
41
-
-
33645790554
-
Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline
-
May
-
Darpo B, Nebout T, Sager PT. Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. J Clin Pharmacol 2006 May; 46 (5): 498-507.
-
(2006)
J Clin Pharmacol
, vol.46
, Issue.5
, pp. 498-507
-
-
Darpo, B.1
Nebout, T.2
Sager, P.T.3
-
42
-
-
12544252367
-
Atypical antipsy- chotics: From potassium channels to torsade de pointes and sudden death
-
Titier K, Girodet PO, Verdoux H, et al. Atypical antipsy- chotics: from potassium channels to torsade de pointes and sudden death. Drug Saf 2005; 28 (1): 35-51.
-
(2005)
Drug Saf
, vol.28
, Issue.1
, pp. 35-51
-
-
Titier, K.1
Girodet, P.O.2
Verdoux, H.3
-
43
-
-
72049116795
-
Thorough QT studies: Questions and quandaries
-
Malik M, Garnett CE, Zhang J. Thorough QT studies: questions and quandaries. Drug Saf 2010; 33 (1): 1-14.
-
(2010)
Drug Saf
, vol.33
, Issue.1
, pp. 1-14
-
-
Malik, M.1
Garnett, C.E.2
Zhang, J.3
-
44
-
-
0242494266
-
What Clinicians Should Know about the QT Interval
-
DOI 10.1001/jama.289.16.2120
-
Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA 2003 Apr 23-30; 289 (16): 2120-7. (Pubitemid 37430214)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.16
, pp. 2120-2127
-
-
Al-Khatib, S.M.1
Allen LaPointe, N.M.2
Kramer, J.M.3
Califf, R.M.4
-
45
-
-
0032713083
-
Influence of food intake on electrocardiograms of healthy male volunteers
-
Nov
-
Widerlov E, Jostell KG, Claesson L, et al. Influence of food intake on electrocardiograms of healthy male volunteers. Eur J Clin Pharmacol 1999 Nov; 55 (9): 619-24.
-
(1999)
Eur J Clin Pharmacol
, vol.55
, Issue.9
, pp. 619-24
-
-
Widerlov, E.1
Jostell, K.G.2
Claesson, L.3
-
47
-
-
27744432195
-
Methods of assessment and clinical relevance of QT dynamics
-
Sredniawa B, Musialik-Lydka A, Jarski P, et al. Methods of assessment and clinical relevance of QT dynamics. Indian Pacing Electrophysiol J 2005; 5 (3): 221-32. (Pubitemid 41581746)
-
(2005)
Indian Pacing and Electrophysiology Journal
, vol.5
, Issue.3
, pp. 221-232
-
-
Sredniawa, B.1
Musialik-Lydka, A.2
Jarski, P.3
Sliwinska, A.4
Kalarus, Z.5
-
48
-
-
7544230831
-
Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation
-
DOI 10.1016/j.jelectrocard.2004.08.005, PII S0022073604000743
-
Malik M. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation. J Electrocardiol 2004; 37 Suppl.: 25-33. (Pubitemid 39452861)
-
(2004)
Journal of Electrocardiology
, vol.37
, Issue.SUPPL.
, pp. 25-33
-
-
Malik, M.1
-
49
-
-
68049118976
-
Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes: Cardiac safety of gadobutrol
-
Jul
-
Malik M, Hnatkova K, Schmidt A, et al. Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes: cardiac safety of gadobutrol. Ann Noninvasive Electrocardiol 2009 Jul; 14 (3): 242-50.
-
(2009)
Ann Noninvasive Electrocardiol
, vol.14
, Issue.3
, pp. 242-50
-
-
Malik, M.1
Hnatkova, K.2
Schmidt, A.3
-
50
-
-
1242270540
-
Beat-to-Beat QT Dynamics in Healthy Subjects
-
DOI 10.1111/j.1542-474X.2004.91510.x
-
Jensen BT, Larroude CE, Rasmussen LP, et al. Beat-to- beat QT dynamics in healthy subjects. Ann Noninvasive Electrocardiol 2004 Jan; 9 (1): 3-11. (Pubitemid 38230424)
-
(2004)
Annals of Noninvasive Electrocardiology
, vol.9
, Issue.1
, pp. 3-11
-
-
Jensen, B.T.1
Larroude, C.E.2
Rasmussen, L.P.3
Holstein-Rathlou, N.-H.4
Hojgaard, M.V.5
Agner, E.6
Kanters, J.K.7
-
51
-
-
0037247453
-
Circadian rhythm of the corrected QT interval: Impact of different heart rate correction models
-
Smetana P, Batchvarov V, Hnatkova K, et al. Circadian rhythm of the corrected QT interval: impact of different heart rate correction models. Pacing Clin Electrophysiol 2003 Jan; 26 (1 Pt 2): 383-6. (Pubitemid 36399177)
-
(2003)
PACE - Pacing and Clinical Electrophysiology
, vol.26
, Issue.1
, pp. 383-386
-
-
Smetana, P.1
Batchvarov, V.2
Hnatkova, K.3
Camm, A.J.4
Malik, M.5
-
52
-
-
67649262232
-
Identifying drug- induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: A study of sotalol effects on T-wave morphology
-
Graff C, Andersen MP, Xue JQ, et al. Identifying drug- induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf 2009; 32 (7): 599-611.
-
(2009)
Drug Saf
, vol.32
, Issue.7
, pp. 599-611
-
-
Graff, C.1
Andersen, M.P.2
Xue, J.Q.3
-
53
-
-
0038488945
-
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
-
DOI 10.1001/archpsyc.60.7.681
-
Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003 Jul; 60: 681-90. (Pubitemid 36818630)
-
(2003)
Archives of General Psychiatry
, vol.60
, Issue.7
, pp. 681-690
-
-
Potkin, S.G.1
Saha, A.R.2
Kujawa, M.J.3
Carson, W.H.4
Ali, M.5
Stock, E.6
Stringfellow, J.7
Ingenito, G.8
Marder, S.R.9
-
54
-
-
0037410337
-
Aripiprazole in the treatment of schizophrenia: Safety and tolerability in short-term, placebo-controlled trials
-
DOI 10.1016/S0920-9964(03)00050-1
-
Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 2003 Jun 1; 61: 123-36. (Pubitemid 36513927)
-
(2003)
Schizophrenia Research
, vol.61
, Issue.2-3
, pp. 123-136
-
-
Marder, S.R.1
McQuade, R.D.2
Stock, E.3
Kaplita, S.4
Marcus, R.5
Safferman, A.Z.6
Saha, A.7
Ali, M.8
Iwamoto, T.9
-
55
-
-
75849147334
-
Effects of oral ziprasidone and oral haloperidol on QTc interval in patients with schizophrenia or schizoaffective disorder
-
Feb
-
Miceli JJ, Tensfeldt TG, Shiovitz T, et al. Effects of oral ziprasidone and oral haloperidol on QTc interval in patients with schizophrenia or schizoaffective disorder. Pharmacotherapy 2010 Feb; 30 (2): 127-35.
-
(2010)
Pharmacotherapy
, vol.30
, Issue.2
, pp. 127-35
-
-
Miceli, J.J.1
Tensfeldt, T.G.2
Shiovitz, T.3
-
56
-
-
1642579574
-
A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition
-
DOI 10.1097/01.jcp.0000104913.75206.62
-
Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 2004 Feb; 24 (1): 62-9. (Pubitemid 38134167)
-
(2004)
Journal of Clinical Psychopharmacology
, vol.24
, Issue.1
, pp. 62-69
-
-
Harrigan, E.P.1
Miceli, J.J.2
Anziano, R.3
Watsky, E.4
Reeves, K.R.5
Cutler, N.R.6
Sramek, J.7
Shiovitz, T.8
Middle, M.9
-
57
-
-
0030770872
-
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
-
DOI 10.1097/00004714-199710000-00010
-
Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997 Oct; 17: 407-18. (Pubitemid 27414397)
-
(1997)
Journal of Clinical Psychopharmacology
, vol.17
, Issue.5
, pp. 407-418
-
-
Tran, P.V.1
Hamilton, S.H.2
Kuntz, A.J.3
Potvin, J.H.4
Andersen, S.W.5
Beasley Jr., C.6
Tollefson, G.D.7
-
58
-
-
0032918379
-
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
-
DOI 10.1016/S0009-9236(99)70117-7
-
Desta Z, Kerbusch T, Flockhart DA. Effect of clarithro- mycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). Clin Pharmacol Ther 1999 Jan; 65: 10-20. (Pubitemid 29062024)
-
(1999)
Clinical Pharmacology and Therapeutics
, vol.65
, Issue.1
, pp. 10-20
-
-
Desta, Z.1
Kerbusch, T.2
Flockhart, D.A.3
-
59
-
-
77950929074
-
The effect of ser- tindole on QTD and TPTE
-
May
-
Nielsen J, Andersen MP, Graff C, et al. The effect of ser- tindole on QTD and TPTE. Acta Psychiatr Scand 2010 May; 121 (5): 385-8.
-
(2010)
Acta Psychiatr Scand
, vol.121
, Issue.5
, pp. 385-8
-
-
Nielsen, J.1
Andersen, M.P.2
Graff, C.3
-
60
-
-
0029801375
-
Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans
-
Hartigan-Go K, Bateman DN, Nyberg G, et al. Con- centration-related pharmacodynamic effects of thiorida-zine and its metabolites in humans. Clin Pharmacol Ther 1996 Nov; 60: 543-53. (Pubitemid 26414090)
-
(1996)
Clinical Pharmacology and Therapeutics
, vol.60
, Issue.5
, pp. 543-553
-
-
Hartigan-Go, K.1
Bateman, D.N.2
Nyberg, G.3
Martensson, E.4
Thomas, S.H.L.5
-
61
-
-
69049119104
-
Sertindole causes dis- tinct electrocardiographic T-wave morphology changes
-
Nielsen J, Graff C, Hardahl T, et al. Sertindole causes dis- tinct electrocardiographic T-wave morphology changes. Eur Neuropsychopharmacol 2009; 19 (10): 702-7.
-
(2009)
Eur Neuropsychopharmacol
, vol.19
, Issue.10
, pp. 702-7
-
-
Nielsen, J.1
Graff, C.2
Hardahl, T.3
-
62
-
-
0038554356
-
Ziprasidone in the management of schizophrenia: The QT interval issue in context
-
DOI 10.2165/00023210-200317060-00004
-
Taylor D. Ziprasidone in the management of schizo- phrenia: the QT interval issue in context. CNS Drugs 2003; 17 (6): 423-30. (Pubitemid 36560704)
-
(2003)
CNS Drugs
, vol.17
, Issue.6
, pp. 423-430
-
-
Taylor, D.1
-
63
-
-
0036050262
-
Clinical management of cardiovascular risks during treatment with psychotropic drugs
-
Glassman AH. Clinical management of cardiovascular risks during treatment with psychotropic drugs. J Clin Psychiatry 2002; 63 Suppl. 9: 12-7.
-
(2002)
J Clin Psychiatry
, vol.63
, Issue.SUPPL. 9
, pp. 12-7
-
-
Glassman, A.H.1
-
64
-
-
20744447216
-
QT interval pro- longation related to psychoactive drug treatment: A comparison of monotherapy versus polytherapy
-
Jan 25
-
Sala M, Vicentini A, Brambilla P, et al. QT interval pro- longation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry 2005 Jan 25; 4 (1): 1.
-
(2005)
Ann Gen Psychiatry
, vol.4
, Issue.1
, pp. 1
-
-
Sala, M.1
Vicentini, A.2
Brambilla, P.3
-
65
-
-
34447123757
-
Cardiovascular effects of antipsychotics
-
DOI 10.1586/14737175.7.7.829
-
Michelsen JW, Meyer JM. Cardiovascular effects of antipsychotics. Expert Rev Neurother 2007 Jul; 7 (7): 829-39. (Pubitemid 47037723)
-
(2007)
Expert Review of Neurotherapeutics
, vol.7
, Issue.7
, pp. 829-839
-
-
Michelsen, J.W.1
Meyer, J.M.2
-
66
-
-
0027296372
-
Measurement of the QT interval and the risk associated with QT(c) interval prolongation: A review
-
Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993 Aug 26; 72 (6): 23B-5B. (Pubitemid 23249060)
-
(1993)
American Journal of Cardiology
, vol.72
, Issue.6
-
-
Moss, A.J.1
-
67
-
-
1442306232
-
Drug-Induced Prolongation of the QT Interval
-
DOI 10.1056/NEJMra032426
-
Roden DM. Drug-induced prolongation of the QT inter- val. N Engl J Med 2004 Mar 4; 350 (10): 1013-22. (Pubitemid 38269278)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.10
, pp. 1013-1022
-
-
Roden, D.M.1
-
68
-
-
0001127258
-
An analysis of the time relationship of electro- cardiograms
-
Bazett HC. An analysis of the time relationship of electro- cardiograms. Heart 1920; 7: 353-70.
-
(1920)
Heart
, vol.7
, pp. 353-70
-
-
Bazett, H.C.1
-
69
-
-
84980091069
-
Die Systolendauer im Elektrokardiogramm bei normalen menschen und bei herzkranken [letter]
-
Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen menschen und bei herzkranken [letter]. Acta Med Scand 1920; 53: 489.
-
(1920)
Acta Med Scand
, vol.53
, pp. 489
-
-
Fridericia, L.S.1
-
70
-
-
33745228747
-
Man versus machine is there an optimal method for QT measurements in thorough QT studies?
-
Jun
-
Darpo B, Agin M, Kazierad DJ, et al. Man versus machine: is there an optimal method for QT measurements in thorough QT studies? J Clin Pharmacol 2006 Jun; 46 (6): 598-612.
-
(2006)
J Clin Pharmacol
, vol.46
, Issue.6
, pp. 598-612
-
-
Darpo, B.1
Agin, M.2
Kazierad, D.J.3
-
71
-
-
9244232876
-
T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome
-
DOI 10.1016/j.hrthm.2004.05.002, PII S1547527104002802
-
Kanters JK, Fanoe S, Larsen LA, et al. T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm 2004 Sep; 1 (3): 285-92. (Pubitemid 39549756)
-
(2004)
Heart Rhythm
, vol.1
, Issue.3
, pp. 285-292
-
-
Kanters, J.K.1
Fanoe, S.2
Larsen, L.A.3
Bloch Thomsen, P.E.4
Toft, E.5
Christiansen, M.6
-
72
-
-
0032519806
-
Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion
-
DOI 10.1016/S0002-9149(97)00927-2, PII S0002914997009272
-
Savelieva I, Yi G, Guo X, et al. Agreement and reprodu- cibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol 1998 Feb 15; 81 (4): 471-7. (Pubitemid 28099540)
-
(1998)
American Journal of Cardiology
, vol.81
, Issue.4
, pp. 471-477
-
-
Savelieva, I.1
Gang, Y.2
Guo, X.-H.3
Hnatkova, K.4
Malik, M.5
-
73
-
-
76949130639
-
The measurement of the Q-T interval of the electrocardiogram
-
Sep
-
Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952 Sep; 6 (3): 378-88.
-
(1952)
Circulation
, vol.6
, Issue.3
, pp. 378-88
-
-
Lepeschkin, E.1
Surawicz, B.2
-
74
-
-
0035200703
-
The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes
-
DOI 10.1177/00912700122012896
-
Tisdale JE, Rasty S, Padhi ID, et al. The effect of in- travenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of torsades de pointes. J Clin Pharmacol 2001 Dec; 41 (12): 1310-8. (Pubitemid 33104898)
-
(2001)
Journal of Clinical Pharmacology
, vol.41
, Issue.12
, pp. 1310-1318
-
-
Tisdale, J.E.1
Rasty, S.2
Padhi, I.D.3
Sharma, N.D.4
Rosman, H.5
-
75
-
-
0031728902
-
Measurement error as a source of QT dispersion: A computerised analysis
-
Kors JA, van Herpen G. Measurement error as a source of QT dispersion: a computerised analysis. Heart 1998 Nov; 80 (5): 453-8. (Pubitemid 28535531)
-
(1998)
Heart
, vol.80
, Issue.5
, pp. 453-458
-
-
Kors, J.A.1
Van Herpen, G.2
-
76
-
-
0032480801
-
Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome
-
Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998 Nov 3; 98 (18): 1928-36. (Pubitemid 28509291)
-
(1998)
Circulation
, vol.98
, Issue.18
, pp. 1928-1936
-
-
Yan, G.-X.1
Antzelevitch, C.2
-
77
-
-
55649114410
-
T(peak) - T(end) interval in long QT syndrome
-
Nov-Dec
-
Kanters JK, Haarmark C, Vedel-Larsen E, et al. T(peak)- T(end) interval in long QT syndrome. J Electrocardiol 2008 Nov-Dec; 41 (6): 603-8.
-
(2008)
J Electrocardiol
, vol.41
, Issue.6
, pp. 603-8
-
-
Kanters, J.K.1
Haarmark, C.2
Vedel-Larsen, E.3
-
78
-
-
77953811288
-
Covariate analysis of QTc and T-wave morphology: New possibilities in the evalua- tion of drugs that affect cardiac repolarization
-
Jul
-
Graff C, Struijk JJ, Matz J, et al. Covariate analysis of QTc and T-wave morphology: new possibilities in the evalua- tion of drugs that affect cardiac repolarization. Clin Pharmacol Ther 2010 Jul; 88 (1): 88-94.
-
(2010)
Clin Pharmacol Ther
, vol.88
, Issue.1
, pp. 88-94
-
-
Graff, C.1
Struijk, J.J.2
Matz, J.3
-
79
-
-
33746929430
-
Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology
-
DOI 10.1007/s11517-006-0061-1
-
Struijk JJ, Kanters JK, Andersen MP, et al. Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology. Med Biol Eng Comput 2006 Jul; 44 (7): 543-9. (Pubitemid 44184466)
-
(2006)
Medical and Biological Engineering and Computing
, vol.44
, Issue.7
, pp. 543-549
-
-
Struijk, J.J.1
Kanters, J.K.2
Andersen, M.P.3
Hardahl, T.4
Graff, C.5
Christiansen, M.6
Toft, E.7
-
80
-
-
55649099614
-
New descriptors of T-wave morphology are independent of heart rate
-
Nov-Dec
-
Andersen MP, Xue JQ, Graff C, et al. New descriptors of T-wave morphology are independent of heart rate. J Electrocardiol 2008 Nov-Dec; 41 (6): 557-61.
-
(2008)
J Electrocardiol
, vol.41
, Issue.6
, pp. 557-61
-
-
Andersen, M.P.1
Xue, J.Q.2
Graff, C.3
-
81
-
-
70350432728
-
Quantitative analysis of T-wave morphology increases confidence in drug-induced cardiac repolarization abnormalities: Evidence from the investigational IKr inhibitor Lu 35-138
-
Nov
-
Graff C, Matz J, Christensen EB, et al. Quantitative analysis of T-wave morphology increases confidence in drug-induced cardiac repolarization abnormalities: evidence from the investigational IKr inhibitor Lu 35-138. J Clin Pharmacol 2009 Nov; 49 (11): 1331-42.
-
(2009)
J Clin Pharmacol
, vol.49
, Issue.11
, pp. 1331-42
-
-
Graff, C.1
Matz, J.2
Christensen, E.B.3
-
82
-
-
33749238020
-
Long QT syn- drome genotyping by electrocardiography: Fact, fiction, or something in between?
-
Oct
-
Kanters JK, Graff C, Andersen MP, et al. Long QT syn- drome genotyping by electrocardiography: fact, fiction, or something in between? J Electrocardiol 2006 Oct; 39 (4 Suppl.): S119-22.
-
(2006)
J Electrocardiol
, vol.39
, Issue.4 SUPPL.
-
-
Kanters, J.K.1
Graff, C.2
Andersen, M.P.3
-
83
-
-
0019959522
-
Electrocardiographic changes and serum concentrations in thioridazine-treated patients
-
Axelsson R, Aspenstrom G. Electrocardiographic changes and serum concentrations in thioridazine-treated patients. J Clin Psychiatry 1982 Aug; 43 (8): 332-5. (Pubitemid 12047325)
-
(1982)
Journal of Clinical Psychiatry
, vol.43
, Issue.8
, pp. 332-335
-
-
Axelsson, R.1
Aspenstrom, G.2
-
84
-
-
0015800945
-
Phenothiazine-induced T-wave abnormalities: Effects of overnight fasting
-
Jun 25
-
Alvarez-Mena SC, Frank MJ. Phenothiazine-induced T-wave abnormalities: effects of overnight fasting. JAMA 1973 Jun 25; 224 (13): 1730-3.
-
(1973)
JAMA
, vol.224
, Issue.13
, pp. 1730-3
-
-
Alvarez-Mena, S.C.1
Frank, M.J.2
-
85
-
-
77957355992
-
Antipsychotic-associated all-cause and cardiac mortality: What should we worry about and how should the risk be assessed?
-
Nov
-
Correll CU, Nielsen J. Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed? Acta Psychiatr Scand 2010 Nov; 122 (5): 341-4.
-
(2010)
Acta Psychiatr Scand
, vol.122
, Issue.5
, pp. 341-4
-
-
Correll, C.U.1
Nielsen, J.2
-
86
-
-
0031954462
-
Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia
-
Daniel DG, Wozniak P, Mack RJ, et al. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia: the Sertindole Study Group. Psychopharmacol Bull 1998; 34 (1): 61-9. (Pubitemid 28176303)
-
(1998)
Psychopharmacology Bulletin
, vol.34
, Issue.1
, pp. 61-69
-
-
Daniel, D.G.1
Wozniak, P.2
Mack, R.J.3
McCarthy, B.G.4
-
87
-
-
77649122136
-
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: A population-based nested case-control study
-
Feb
-
Baandrup L, Gasse C, Jensen VD, et al. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry 2010 Feb; 71 (2): 103-8.
-
(2010)
J Clin Psychiatry
, vol.71
, Issue.2
, pp. 103-8
-
-
Baandrup, L.1
Gasse, C.2
Jensen, V.D.3
-
88
-
-
0031668084
-
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study
-
Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia: antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 1998 Oct; 173: 325-9. (Pubitemid 28454819)
-
(1998)
British Journal of Psychiatry
, vol.173
, Issue.OCT.
, pp. 325-329
-
-
Waddington, J.L.1
Youssef, H.A.2
Kinsella, A.3
-
89
-
-
44949193763
-
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing
-
DOI 10.1192/bjp.bp.107.042895
-
Paton C, Barnes TR, Cavanagh MR, et al. High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br J Psychiatry 2008 Jun; 192 (6): 435-9. (Pubitemid 351809896)
-
(2008)
British Journal of Psychiatry
, vol.192
, Issue.6
, pp. 435-439
-
-
Paton, C.1
Barnes, T.R.E.2
Cavanagh, M.-R.3
Taylor, D.4
Lelliott, P.5
-
90
-
-
77957348105
-
10-year trends in the treatment and outcomes of patients with first-episode schizophrenia
-
Nov
-
Nielsen J, le Quach P, Emborg C, et al. 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr Scand 2010 Nov; 122 (5): 356-66.
-
(2010)
Acta Psychiatr Scand
, vol.122
, Issue.5
, pp. 356-66
-
-
Nielsen, J.1
Le Quach, P.2
Emborg, C.3
-
91
-
-
48949085884
-
The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe
-
Lancon C, Toumi M, Sapin C, et al. The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe. BMC Psychiatry 2008; 8: 57.
-
(2008)
BMC Psychiatry
, vol.8
, pp. 57
-
-
Lancon, C.1
Toumi, M.2
Sapin, C.3
-
92
-
-
77950352932
-
The European post-mar- keting observational sertindole study: An investigation of the safety of antipsychotic drug treatment
-
Feb
-
Kasper S, Moller HJ, Hale A. The European post-mar- keting observational sertindole study: an investigation of the safety of antipsychotic drug treatment. Eur Arch Psychiatry Clin Neurosci 2010 Feb; 260 (1): 59-68.
-
(2010)
Eur Arch Psychiatry Clin Neurosci
, vol.260
, Issue.1
, pp. 59-68
-
-
Kasper, S.1
Moller, H.J.2
Hale, A.3
-
93
-
-
34547554319
-
The European sertindole safety and exposure survey: A follow-up study of 8600 patients
-
DOI 10.1002/pds.1425
-
Peuskens J, Moore N, Azorin JM, et al. The European sertindole safety and exposure survey: a follow-up study of 8600 patients. Pharmacoepidemiol Drug Saf 2007 Jul; 16 (7): 804-11. (Pubitemid 47180370)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.7
, pp. 804-811
-
-
Peuskens, J.1
Moore, N.2
Azorin, J.-M.3
Toumi, M.4
Cochran, J.5
-
94
-
-
79952718641
-
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Zi-prasidone Observational Study of Cardiac Outcomes (ZODIAC)
-
Strom BL, Eng SM, Faich G, et al. Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: the Zi-prasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry 2011 Feb; 168 (2): 193-201.
-
Am J Psychiatry 2011 Feb
, vol.168
, Issue.2
, pp. 193-201
-
-
Strom, B.L.1
Eng, S.M.2
Faich, G.3
-
95
-
-
77953731103
-
Psychiatrists' attitude towards and knowledge of clozapine treatment
-
Jul
-
Nielsen J, Dahm M, Lublin H, et al. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psy-chopharmacol 2010 Jul; 24 (7): 965-71.
-
(2010)
J Psy-chopharmacol
, vol.24
, Issue.7
, pp. 965-71
-
-
Nielsen, J.1
Dahm, M.2
Lublin, H.3
-
96
-
-
0036917165
-
Investigation of the potential of clozapine to cause Torsade de Pointes
-
Warner B, Hoffmann P. Investigation of the potential of clozapine to cause torsade de pointes. Adverse Drug React Toxicol Rev 2002; 21 (4): 189-203. (Pubitemid 36018766)
-
(2002)
Adverse Drug Reactions and Toxicological Reviews
, vol.21
, Issue.4
, pp. 189-203
-
-
Warner, B.1
Hoffmann, P.2
-
97
-
-
61849118370
-
Clozapine-induced cardio- toxicity: A clinical update
-
Feb 16
-
Layland JJ, Liew D, Prior DL. Clozapine-induced cardio- toxicity: a clinical update. Med J Aust 2009 Feb 16; 190 (4): 190-2.
-
(2009)
Med J Aust
, vol.190
, Issue.4
, pp. 190-2
-
-
Layland, J.J.1
Liew, D.2
Prior, D.L.3
-
98
-
-
0842348094
-
Consensus development conference on antipsychotic drugs and obesity and diabetes
-
ADA Feb
-
ADA. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004 Feb; 27 (2): 596-601.
-
(2004)
Diabetes Care
, vol.27
, Issue.2
, pp. 596-601
-
-
-
99
-
-
58349114440
-
Antipsychotic agents and sudden cardiac death how should we manage the risk?
-
Jan 15
-
Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death: how should we manage the risk? N Engl J Med 2009 Jan 15; 360 (3): 294-6.
-
(2009)
N Engl J Med
, vol.360
, Issue.3
, pp. 294-6
-
-
Schneeweiss, S.1
Avorn, J.2
-
100
-
-
77954762965
-
Antipsychotics asso- ciated with the development of type 2 diabetes in anti-psychotic-naive schizophrenia patients
-
Aug
-
Nielsen J, Skadhede S, Correll CU. Antipsychotics asso- ciated with the development of type 2 diabetes in anti-psychotic-naive schizophrenia patients. Neuropsycho-pharmacology 2010 Aug; 35 (9): 1997-200.
-
(2010)
Neuropsycho-pharmacology
, vol.35
, Issue.9
, pp. 1997-200
-
-
Nielsen, J.1
Skadhede, S.2
Correll, C.U.3
-
102
-
-
0347064997
-
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment
-
Meltzer HY, Davidson M, Glassman AH, et al. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J Clin Psychiatry 2002; 63 Suppl. 9: 25-9
-
(2002)
J Clin Psychiatry
, vol.63
, Issue.SUPPL. 9
, pp. 25-9
-
-
Meltzer, H.Y.1
Davidson, M.2
Glassman, A.H.3
|